Baby Boomer Screening Targets the Most Vulnerable to HCV Morbidity and Mortality 73% of HCV-related deaths are in this cohort. A one-time-only hepatitis.

Slides:

Advertisements

Similar presentations

The effect of improved HCV diagnosis and treatment on public health The effect of improved HCV diagnosis and treatment on public health P Mathurin Hôpital.

Advertisements

Impact of Alzheimer’s Disease in Minnesota Broadening the Research Agenda to Meet the Challenge Steve Waring DVM, PhD, FACE Senior Research Scientist Essentia.

BVCOG HRSA/HAB Tier 2 and 3 Performance Measures Lisa Cornelius, MD, MPH July 2010.

Hepatitis C In Alaska’s Department of Corrections

Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.

Hepatitis web study H EPATITIS W EB S TUDY Christian B. Ramers, MD, MPH Assistant Medical Director, Family Health Centers of San Diego HIV/HCV Distance.

HIV/AIDS Prevention Committee Public Meeting November 21, 2013.

Cost-Effectiveness of a One-Time National Hepatitis C Screening Program: Impact of a Selective Drug Reimbursement Policy CADTH Symposium April 14, 2015.

A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.

Factors associated with hepatitis B serologic screening in a population- based survey of Korean Americans from Washington state Adeena Khan, MD 1 Genji.

HIV-Hepatitis C Virus Co-infection: An Evolving Epidemic Marina B. Klein, MD, MSc, FRCP(C) Division of Infectious Diseases and Chronic Viral Illness Service.

Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.

Modelled impact of antiviral therapy on the future burden of HCV disease in Scotland Testing/Treatment/Care Working Group, 11 th Sept 2007.

Managing Hepatitis C: An Unprecedented Correctional Healthcare Challenge ASCA/CCHA meeting Phoenix, AZ RADM Newton E. Kendig Assistant Director/Medical.

Wyoming Department of Health Communicable Diseases

Division of Viral Hepatitis

Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.

Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.

Tackling hepatitis C - what PHE modelling shows us Helen Harris BSc PhD FFPH LJWG meeting; November 2014.

What is hepatitis B? Hepatitis B is a virus that infects the liver.

HIV Among People Aged 50 and Older Trainer Slides May 2015.

Patient Information - Viral Hepatitis B (HBV)

Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.

I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.

HIV Disease and Hepatitis C Virus (HCV) Co-Infection – Florida, 2011 HIV/AIDS & Hepatitis Program - Surveillance Section HIV Disease data from 1981 through.

The Swiss Population In 2001 Resident population: 7,258,500 Population density: 176 per Km 2 Foreign nationals: 20.1% (~1,460,000) Excess of births over.

The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.

Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.

Pennsylvania: The State of HCV 2015

The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.

Kow-Tong Chen, M.D., Ph.D., Hsiao-Ling Chang, Ph.D., Chu-Tzu Chen, M.P.H., and Ying-An Chen, M.P.H. Volume 23, Number 3, 2009 AIDS PATIENT CARE and STDs.

Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.

Prevention, Treatment and Care of Hepatitis C among People Who Inject Drugs Jason Grebely, PhD Senior Lecturer Viral Hepatitis Clinical Research Program.

Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.

Importance of HIV Education of HIV Screening and Risk Among Adults 65 Years Old and Older In A Senior Center JESSICA WARD RN,BSN,FNP COPPIN STATE UNIVERSITY.

From discovery to cure in 25 years -- the Hepatitis C story Mel Krajden MD, FRCPC Medical Head, Hepatitis Acting Medical Director, Public Health Laboratory.

More than half a million individuals in Taiwan experience chronic HCV infection (1). Nosocomial transmission has been minimized after the implementation.

Innovative Strategies for Addressing Hepatitis C in Indian Country March 14, 2016.

Date of download: 6/1/2016 From: Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons Ann Intern Med. 2016;164(2): doi: /M

Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.

HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.

What is the contribution of alcohol to liver disease in the hepatitis C infected population. The epidemiological evidence Hamish Innes Research Fellow.

Setting the Scene. Non A, non B Hepatitis  Early 1970’s recognised that 2/3 of post transfusional hepatitis were –ve for both Hep A & Hep B Non Hep A.

Template ID: junglegreens Size: 36x48 Impact of Hepatitis C Screening in Outpatient Population Madhuri Chandnani MD, Pallavi Pothuri MD, Michael Stevens.

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Addressing Viral Hepatitis

Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator

A one-year audit of topics and domains in the Journal of the American Medical Association and the New England Journal of Medicine1 Steven H Woolf, MD,

Hepatitis C Incidence and Prevalence in the U.S.

Young People Newly Diagnosed with Hepatitis C in New York City

Estimated number of annual AIDS cases,

Chronic Hepatitis C Virus Infection

Jonathan Mermin, MD, MPH RADM, USPHS

Death rates: US Mortality Volumes 1930 to 1959, US Mortality Data 1960 to 2014, National Center for Health Statistics, Centers for Disease Control and.

Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D

HCV: Who Should We Screen and Why?

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

More Than Treatment.

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Hepatitis C in the HIV-infected patient

US Outbreak Investigations Highlight the Need for Safe Injection Practices and Basic Infection Control Joseph F. Perz, DrPH, MA, Nicola D. Thompson,

Presented by: Jeanette Shabazz, PhD, NP-C

Treatment of hepatitis C

William S. Asch, Margaret J. Bia Advances in Chronic Kidney Disease

Hepatitis C Virus Infection in the Older Patient

Hepatitis C Virus Diagnosis and the Holy Grail

Lesson 3: The HCV Care Continuum

Managing Hepatitis C in Vermont

Presentation transcript:

Baby Boomer Screening Targets the Most Vulnerable to HCV Morbidity and Mortality 73% of HCV-related deaths are in this cohort. A one-time-only hepatitis C Screen-Treat-Cure program in Canada for Baby Boomers would prevent at least 21,000 HCV-related deaths This sort of screen-treat-cure approach “is likely to be cost-effective, at $34,359 to $44,034 per QALY (Quality-Adjusted Year of Life) gained…” Sources: CDC: Centers for Disease Control and Prevention (August, 2012) and Cost-effectiveness of screening for hepatitis C in Canada, William W.L. Wong PhD, Hong-Anh Tu PhD, Jordan J. Feld MD MPH, Tom Wong MD MPH, Murray Krahn MD MSc

Risk of Transmission vs. Risk of Dying Years of Age Chart: Jason Grebely, et al CID 2013 Younger people are at greater risk of contracting or transmitting HCV (Hepatitis C Virus) and generally need targeted RISK-BASED PREVENTION-MONITOR-TREAT-CURE programs. Older people (who may have used drugs at one time) are at far greater risk of HCV-related morbidity and mortality, and generally need an AGE COHORT BASED 1 TIME SCREEN-TREAT-CURE program. Risk of HCV Transmission Risk of Liver-Related Morbidity & Mortality

HCV: A LIFE AND DEATH ISSUE Ly et al. Annals of Internal Medicine. 2012; 156: Since 2006, more people have died of hepatitis C than of either HIV/AIDS or of hepatitis B.

Who is living with chronic hepatitis C in Canada? Approx. 75% of these 220,000 people are Baby Boomers. Approx. 80% of them are not current users of IV drugs. Data Source: Cdn Communicable Disease ReportCCDR: Volume 40-19, December 18, %

Hepatitis C damages “silently.” You can have it and not know it. It is CURABLE if diagnosed and treated in time (before liver decompensates). Hepatitis C liver damage is REVERSIBLE once the virus is gone.

Some faces of Baby Boomers with hepatitis C in British Columbia All are members of HepCBC who have made their diagnosis public in hopes of erasing stigma…